Efficacy of uric acid ‐lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients

ConclusionUric acid ‐lowering therapy benefits hyperlipidemia in gouty patients. Febuxostat effectively improved serum cholesterol and triglyceride levels compared to allopurinol and benzbromarone in patients with gout.

Source: International Journal of Rheumatic Diseases - July 16, 2019 Category: Rheumatology Authors: Jing Wu, Yu ‐Ping Zhang, Yuan Qu, Li‐Gang Jie, Jia‐Xin Deng, Qing‐Hong Yu Tags: ORIGINAL ARTICLE Source Type: research